DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Mohga Kamal - 1 Reig - 1 Maggie Fick - 1 Jennifer Rigby - 1 Elaine Hardcastle - 1
Top related locs:
Europe Ireland Belgium Netherlands London
Top related orgs:
European Commission - 1 Pfizer - 1 EU - 1 World Health Organization - 1 People’s Vaccine - 1 Laboratorios Hipra SA - 1 World Health - 1 Thomson - 1

Search resuls for: "Reig"


2 mentions found


☆ EU announces deal with Pfizer, others to reserve vaccines for future pandemic
  + stars: | 2023-06-30 | by ( Maggie Fick | ) www.reuters.com   time to read: +2 min
LONDON, June 30 (Reuters) - The European Commission has contracted Pfizer (PFE.N) and several European companies to reserve capacity to make up to 325 million vaccines per year in case of a future global health emergency, it said on Friday. The European Commission said in a statement announcing the deal that the COVID pandemic showed that Europe needs to be better prepared for future health emergencies. But vaccine equity activists said the EU risked a repeat of what the World Health Organization dubbed "vaccine apartheid" during COVID-19. The Commission has selected Pfizer's plants in Ireland and Belgium to reserve capacity to produce mRNA vaccines. It selected Spanish companies Reig Jofre (RJFE.MC) and Laboratorios Hipra SA to reserve capacity for protein-based vaccines and Bilthoven Biologicals B.V. of the Netherlands for vector-based vaccines.
Persons: Mohga Kamal, Reig, Maggie Fick, Jennifer Rigby, Elaine Hardcastle Organizations: European Commission, Pfizer, Reuters, EU, World Health Organization, People’s Vaccine, Laboratorios Hipra SA, World Health, Thomson Locations: Europe, Ireland, Belgium, Netherlands, London
☆ Why Europe's drug shortages may get worse
  + stars: | 2023-02-08 | by ( Maggie Fick Natalie Grover | Maggie Fick | Natalie Grover | ) www.reuters.com   time to read: +10 min
Much as he would have liked to significantly increase supplies, Biosca-Reig said he couldn't justify investing millions of euros in new production lines unless he was paid more for the generic drug to cover sharply rising costs. European generic drugmakers say the tender system and regulated prices have fuelled a race to the bottom, and European firms are being undercut by suppliers from Asia. BRUSSELS, WE HAVE A PROBLEMThe European Medicines Agency (EMA) and European Union lawmakers acknowledge there is a problem. Half the generic medicines sold in Spain are priced below 1.60 euros per box or bottle, the country's generics manufacturing association said. But companies with smaller market shares, such as Israel's Teva (TEVA.TA), which has 5% of the region's amoxicillin market according to Medicines for Europe, are constrained.
0 next >>
Total: 2